Altered Platelet Plug Formation in Hyperthyroidism and Hypothyroidism
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Patients with thyroid diseases have abnormalities of blood coagulation including an alteration of von Willebrand factor (vWF) levels. Because vWF plays an important role in primary hemostasis, we hypothesized that heightened and decreased vWF levels in hyper- and hypothyroidism enhance and decrease platelet plug formation, respectively. METHODS: We followed a cohort of 120 patients with overt hyperthyroidism, patients with subclinical and overt hypothyroidism, and euthyroid controls. vWF and in vitro platelet plug formation as collagen-epinephrine-induced closure time (CEPI-CT) were measured at baseline and during therapy with thiamazole or T(4). RESULTS: Baseline vWF levels were higher in patients with hyperthyroidism and lower in patients with overt hypothyroidism than in controls (P < 0.01). High vWF antigen levels were associated with increased baseline platelet plug formation in patients with hyperthyroidism as compared with controls [114 sec (95% confidence interval, 105-122 sec) vs. 130 sec (120-140 sec), P = 0.01]. After 8 wk of therapy with thiamazole, serum concentrations of T(4) and vWF levels decreased to normal values (P < 0.01 vs. baseline), and CEPI-CT was prolonged as compared with baseline (P < 0.01). During therapy with T(4), vWF levels increased (P < 0.05 vs. baseline) and CEPI-CT was shortened as compared with baseline (P < 0.01). CONCLUSION: Hyperthyroidism-induced vWF elevation is associated with enhanced platelet function and therefore shortened CEPI-CT values. These changes may contribute to the higher risk for cardiovascular disease in patients with hyperthyroidism. Platelet plug formation decreases during therapy with thiamazole. Furthermore, CEPI-CT appears to be sensitive to detect acquired von Willebrand disease associated with overt hypothyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899 · cited 1×
“This could explain why very old individuals with elevated levels of TSH have a better survival than patients with normal TSH levels (38).”
BackgroundParle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669 · cited 1×
“Long-term follow-up studies have revealed increased mortality from cardiovascular and cerebrovascular disease in those with a past history of overt hyperthyroidism (10) as well as in those with subclinical hyperthyroidism indicated by a low serum TSH concentration (11).”
BackgroundSubclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536 · cited 1×
“On the contrary, subclinical hypothyroidism was shown as an independent risk factor for atherosclerosis, myocardial infarction, and coronary heart disease (40, 41).”
BackgroundPlatelet function predicts myocardial damage in patients with acute myocardial infarction
Frossard, M., Fuchs, I., Leitner, J. M., Hsieh, K., Vlcek, M., Losert, H., Domanovits, H., Schreiber, W., Laggner, A. N., & Jilma, B. (2004) · Circulation · doi:10.1161/01.cir.0000141575.92958.9c · Cited by 254
Self-citationThyroid Diseases and Cerebrovascular Disease
Squizzato, A., Gerdes, V. E. A., Brandjes, D. P. M., Büller, H. R., & Stam, J. (2005) · Stroke · doi:10.1161/01.str.0000181772.78492.07 · Cited by 236
Primary haemostasis in thyroid disease
MYRUP, B., BREGENGÅRD, C., & FABER, J. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00899.x · Cited by 72
Cited by
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
“Patients with thyroid diseases have abnormalities of blood coagulation that may contribute to the high risk for cardiovascular disease (208).”
BackgroundThyroid Hormones and Cardiovascular Function and Diseases
Razvi, S., Jabbar, A., Pingitore, A., Danzi, S., Biondi, B., Klein, I., Peeters, R., Zaman, A., & Iervasi, G. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.045 · Cited by 515
Risk factors for chronic thromboembolic pulmonary hypertension
Bonderman, D., Wilkens, H., Wakounig, S., Schäfers, H.-J., Jansa, P., Lindner, J., Simkova, I., Martischnig, A. M., Dudczak, J., Sadushi, R., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00087608 · Cited by 441
Update on Chronic Thromboembolic Pulmonary Hypertension
Lang, I. M., & Madani, M. (2014) · Circulation · doi:10.1161/circulationaha.114.009309 · Cited by 305
The influence of thyroid function on the coagulation system and its clinical consequences
Elbers, L. P. B., Fliers, E., & Cannegieter, S. C. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13970 · Cited by 123
Hyperthyroidism and Risk of Ischemic Stroke in Young Adults: A 5-Year Follow-Up Study
Sheu, J.-J., Kang, J.-H., Lin, H.-C., & Lin, H.-C. (2010) · Stroke · doi:10.1161/strokeaha.109.577742 · Cited by 104
Franchini, M., Lippi, G., & Targher, G. (2011) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029610364521 · Cited by 71
“Homoncik and colleagues found increased plasma von Willebrand factor (VWF) levels and enhanced platelet function (as measured with the PFA-100 analyzer) in patients with overt hyperthyroidism compared with euthyroid controls.(48) Loeliger and colleagues found that overt hyperthyroidism may significantly increase the t…”
BackgroundVAN ZAANE, B., SQUIZZATO, A., DEBEIJ, J., DEKKERS, O. M., MEIJERS, J. C. M., VAN ZANTEN, A. P., BÜLLER, H. R., GERDES, V. E. A., CANNEGIETER, S. C., & BRANDJES, D. P. M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04430.x · Cited by 46
Metadata
- Authors
- Homoncik, M., Gessl, A., Ferlitsch, A., Jilma, B., & Vierhapper, H.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-08-01
- Volume
- 92
- Issue
- 8
- Pages
- 3006-3012
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2080861502
- Cited by
- 123
- References
- 6
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.